{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:00Z","timestamp":1787020140035,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although Brazil has one of the largest populations on haemodialysis (HD) in the world, data regarding patients\u2019 characteristics and the variables associated with risk of death are scanty.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a retrospective analysis of all adult patients who initiated on maintenance HD at 23 dialysis centres in Brazil between 2012 and 2017. Patients were censored after 60 months of follow-up or at the end of 2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 5,081 patients were included in the analysis. The median age was 59 years, 59.4% were men, 37.5% had diabetes as the cause of kidney failure. Almost 70% had a central venous catheter (CVC) as the initial vascular access, about 60% started dialysis in the hospital, and fluid overload (FO) by bioimpedance assessment was seen in 45% of patients. The 60-month survival rate was 51.4%. In the Cox regression analysis, being older (\n                      <jats:italic>P<\/jats:italic>\n                      &lt;0.0001), starting dialysis in the hospital (\n                      <jats:italic>P<\/jats:italic>\n                      =0.016), having diabetes as the cause of kidney failure (\n                      <jats:italic>P<\/jats:italic>\n                      =0.001), high alkaline phosphatase (\n                      <jats:italic>P<\/jats:italic>\n                      =0.005), CVC as first vascular access (\n                      <jats:italic>P<\/jats:italic>\n                      =0.023), and FO (\n                      <jats:italic>P<\/jats:italic>\n                      &lt;0.0001) were associated with higher death risk, whereas higher body mass index (\n                      <jats:italic>P<\/jats:italic>\n                      =0.015), haemoglobin (\n                      <jats:italic>P<\/jats:italic>\n                      =0.004), transferrin saturation (\n                      <jats:italic>P<\/jats:italic>\n                      =0.002), and serum albumin (\n                      <jats:italic>P<\/jats:italic>\n                      &lt;0.0001) were associated with better survival. The same variables, except initial CVC use (\n                      <jats:italic>P<\/jats:italic>\n                      =0.14), were associated with death risk in an analysis of subdistribution proportional hazards ratio including the competing outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The present study gives an overview of a large HD population in a developing country and identifies the main predictors of mortality, including some potentially modifiable ones, such as unplanned initiation of dialysis in the hospital and fluid overload.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-022-02705-x","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T01:12:55Z","timestamp":1645578775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Characteristics and predictors of mortality on haemodialysis in Brazil: a cohort of 5,081 incident patients"],"prefix":"10.1186","volume":"23","author":[{"given":"Ana Beatriz Lesqueves","family":"Barra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Roque-da-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Eugenia F.","family":"Canziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocemir R.","family":"Lugon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Paulo","family":"Strogoff-de-Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,23]]},"reference":[{"key":"2705_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1590\/2175-8239-jbn-2019-0234","volume":"42","author":"PDMM Neves","year":"2020","unstructured":"Neves PDMM, Sesso RCC, Thom\u00e9 FS, Lugon JR, Nascimento MM. Brazilian Dialysis Census: analysis of data from the 2009-2018 decade. J Bras Nefrol. 2020;42:191\u2013200.","journal-title":"J Bras Nefrol"},{"key":"2705_CR2","unstructured":"United States Renal Data System. 2020 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2020."},{"key":"2705_CR3","unstructured":"ERA-EDTA Registry: ERA-EDTA Registry Annual Report 2019. Amsterdam UMC, location AMC, Department of Medical Informatics, Amsterdam, the Netherlands, 2021."},{"key":"2705_CR4","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/ki.2013.252","volume":"85","author":"BM Robinson","year":"2014","unstructured":"Robinson BM, Zhang J, Morgenstern H, et al. Worldwide, mortality risk is high soon after initiation of hemodialysis. Kidney Int. 2014;85:158\u201365.","journal-title":"Kidney Int"},{"key":"2705_CR5","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.2215\/CJN.00640109","volume":"4","author":"D Miskulin","year":"2009","unstructured":"Miskulin D, Bragg-Gresham J, Gillespie BW, et al. Key comorbid conditions that are predictive of survival among hemodialysis patients. Clin J Am Soc Nephrol. 2009;4:1818\u201326.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2705_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2147\/CLEP.S233197","volume":"12","author":"A Karaboyas","year":"2020","unstructured":"Karaboyas A, Morgenstern H, Li Y, et al. Estimating the fraction of first-year hemodialysis deaths attributable to potentially modifiable risk factors: Results from the DOPPS. Clin Epidemiol. 2020;12:51\u201360.","journal-title":"Clin Epidemiol"},{"key":"2705_CR7","doi-asserted-by":"publisher","first-page":"l5873","DOI":"10.1136\/bmj.l5873","volume":"367","author":"AK Bello","year":"2019","unstructured":"Bello AK, Levin A, Lunney M, et al. Status of care for end stage kidney disease in countries and regions worldwide: international cross-sectional survey. BMJ. 2019;367:l5873.","journal-title":"BMJ"},{"key":"2705_CR8","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1681\/ASN.2016121341","volume":"28","author":"C Zoccali","year":"2017","unstructured":"Zoccali C, Moissl U, Chazot C, et al. Chonic Fluid overload and mortality in ESRD. J Am Soc Nephrol. 2017;28:2491\u20137.","journal-title":"J Am Soc Nephrol"},{"key":"2705_CR9","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496\u2013509.","journal-title":"J Am Stat Assoc"},{"key":"2705_CR10","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1590\/S0101-28002011000400008","volume":"33","author":"JP Matos","year":"2011","unstructured":"Matos JP, Almeida JR, Guinsburg A, et al. Assessment of a five-year survival on hemodialysis in Brazil: a cohort of 3,082 incident patients. J Bras Nefrol. 2011;33:436\u201341.","journal-title":"J Bras Nefrol"},{"key":"2705_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2215\/CJN.01170905","volume":"2","author":"BD Bradbury","year":"2007","unstructured":"Bradbury BD, Fissell RB, Albert JM, et al. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol. 2007;2:89\u201399.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2705_CR12","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJM199309303291404","volume":"329","author":"WF Owen Jr","year":"1993","unstructured":"Owen WF Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med. 1993;329:1001\u20136.","journal-title":"N Engl J Med"},{"key":"2705_CR13","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/sj.ki.5002769","volume":"73","author":"FC Barreto","year":"2008","unstructured":"Barreto FC, Barreto FC, Barreto DV, et al. K\/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients. Kidney Int. 2008;73:771\u20137.","journal-title":"Kidney Int"},{"key":"2705_CR14","first-page":"264","volume":"33","author":"K Sumida","year":"2018","unstructured":"Sumida K, Molnar MZ, Potukuchi PK, et al. Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis. Nephrol Dial Transplant. 2018;33:264\u201373.","journal-title":"Nephrol Dial Transplant"},{"key":"2705_CR15","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1681\/ASN.2020101531","volume":"32","author":"M Guedes","year":"2021","unstructured":"Guedes M, Muenz DG, Zee J, Bieber B, et al. Serum biomarkers of iron stores are associated with increased risk of all-cause mortality and cardiovascular events in nondialysis CKD patients, with or without anemia. J Am Soc Nephrol. 2021;32:2020\u201330.","journal-title":"J Am Soc Nephrol"},{"key":"2705_CR16","doi-asserted-by":"publisher","first-page":"e0236277","DOI":"10.1371\/journal.pone.0236277","volume":"15","author":"T Kuragano","year":"2020","unstructured":"Kuragano T, Joki N, Hase H, et al. Low transferrin saturation (TSAT) and high ferritin levels are significant predictors for cerebrovascular and cardiovascular disease and death in maintenance hemodialysis patients. PLoS One. 2020;15:e0236277.","journal-title":"PLoS One"},{"key":"2705_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000499758","volume":"48","author":"M Sato","year":"2019","unstructured":"Sato M, Hanafusa N, Tsuchiya K, Kawaguchi H, Nitta K. Impact of transferrin saturation on all-cause mortality in patients on maintenance hemodialysis. Blood Purif. 2019;48:158\u201366.","journal-title":"Blood Purif"},{"key":"2705_CR18","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1056\/NEJMoa1810742","volume":"380","author":"IC Macdougall","year":"2019","unstructured":"Macdougall IC, White C, Anker SD, et al. Intravenous iron in patients undergoing maintenance hemodialysis. N Engl J Med. 2019;380:447\u201358.","journal-title":"N Engl J Med"},{"key":"2705_CR19","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1093\/ndt\/gfv379","volume":"31","author":"M Doshi","year":"2016","unstructured":"Doshi M, Streja E, Rhee CM, et al. Examining the robustness of the obesity paradox in maintenance hemodialysis patients: a marginal structural model analysis. Nephrol Dial Transplant. 2016;31:1310\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"2705_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12882-020-01821-w","volume":"21","author":"ABL Barra","year":"2020","unstructured":"Barra ABL, Roque-da-Silva AP, Vasconcellos MS, Lugon JR, Strogoff-de-Matos JP. Association between extracellular volume control and survival in patients on short daily haemodialysis. BMC Nephrol. 2020;21:153.","journal-title":"BMC Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02705-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-022-02705-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02705-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T01:14:46Z","timestamp":1645578886000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-022-02705-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,23]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2705"],"URL":"https:\/\/doi.org\/10.1186\/s12882-022-02705-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,23]]},"assertion":[{"value":"9 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the Declaration of Helsinki. The project was approved by the research ethics committee of the Department of Medicine, Universidade Federal Fluminense, Niter\u00f3i, RJ, Brazil. Approved Project Number: CAAE 76623317.10000.5243. No written informed consent was requested due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A.B.L.B. is a Fresenius Medical Care Brazil employee.J.P.S.M and M.E.F.C. received consultancy fees from Fresenius Medical Care Brazil.A.P.R.S and J.R.L declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}